Cardiomo
Amsterdam
About Cardiomo
AI-based solution for remote patient monitoring and diagnostics that enables smart, continuous, real time and cost-effective monitoring of patients outside of hospital settings. Solution consists of wearable patch and cloud-based analytic platform and provides early detection of arrhythmias with almost no healthcare professionals involvement, establishing a more robust relationship between patients and providers and improving patient outcomes. Solution monitors patient vitals (such as ECG, BPM, respiration rate, temperature, body position), analyzes the data and predicts critical cases in real-time as well as provides additional relevant information to patient, family members and healthcare professionals. Cardiomo solution enables home-based monitoring that can reduce infection risks for patients, communities and providers and help seniors, patients with CVD and related diseases to stay at home to avoid unnecessary visits to hospitals.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $976.8K
- Funding stage: Seed
- Last round: Grant (Sep 2021)
- Website: cardiomo.com
- Phone: +31 651178284
Industries & Categories
Artificial Intelligence (AI), Health Care, Machine Learning, Medical Device, Wearables
Social Profiles
Canonical: https://fsome.com/organization/cardiomo-77245 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.